Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

7.7%

1 terminated out of 13 trials

Success Rate

90.0%

+3.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

11%

1 of 9 completed with results

Key Signals

1 with results90% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (12)

Trial Status

Completed9
Unknown1
Withdrawn1
Terminated1
Recruiting1

Trial Success Rate

90.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (13)

Research Network

Activity Timeline